🇺🇸 FDA
Patent

US 11242543

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

granted A61KA61K38/465A61K48/00

Quick answer

US patent 11242543 (Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription) held by The Regents of the University of California expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K38/465, A61K48/00, A61P, A61P31/00